Close the Round-Tripping Loophole Act

Read twice and referred to the Committee on Finance.

• Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Finance Committee
  Senate

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• ELEKTA, INC.
  for ELEKTA, INC. · District of Columbia · 3rd Quarter 2025 (July 1 - Sep 30)
• ELEKTA, INC.
  for ELEKTA, INC. · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
• THE WASHINGTON TAX & PUBLIC POLICY GROUP
  for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
• THE WASHINGTON TAX & PUBLIC POLICY GROUP
  for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · District of Columbia · 3rd Quarter 2025 (July 1 - Sep 30)
• THE WASHINGTON TAX & PUBLIC POLICY GROUP
  for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · District of Columbia · 2nd Quarter 2025 (Apr 1 - June 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  5 filings
• SENATE
  5 filings
• Centers For Medicare and Medicaid Services (CMS)
  2 filings
• Commerce, Dept of (DOC)
  2 filings
• Health & Human Services, Dept of (HHS)
  2 filings
• Nuclear Regulatory Commission (NRC)
  2 filings
• U.S. Trade Representative (USTR)
  2 filings
• Energy, Dept of
  1 filing

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.